Exchanges At Goldman Sachs
Vaccine Progress and What’s Next
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:09:56
- Mais informações
Informações:
Sinopse
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution. Learn more about your ad choices. Visit megaphone.fm/adchoices
